Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Let’s cut to the chase: erectile dysfunction ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

putting the cost basis of the shares at $24.40 (before broker commissions). To an investor already interested in purchasing shares of HIMS, that could represent an attractive alternative to paying ...

Hims & Hers Health, Inc. (HIMS) closed at $29.72 in the latest trading session, marking a -0.3% move from the prior day. This move lagged the S&P 500's daily gain of 0.61%. Elsewhere, the Dow ...

View Hims & Hers Health, Inc. (HIMS) current and estimated P/E ratio data provided by Seeking Alpha.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Viagra (sildenafil) is an oral drug used to treat erectile dysfunction (ED) that starts working within one hour and can last for around four hours. It was the first drug approved for the use of ED, a ...